MedPageToday -- A new hybrid measure of response to therapy in rheumatoid arthritis is more sensitive than the standard American College of Rheumatology (ACR) 20%, 50%, and 70% response criteria, a post-hoc analysis showed.
MedPageToday -- A new hybrid measure of response to therapy in rheumatoid arthritis is more sensitive than the standard American College of Rheumatology (ACR) 20%, 50%, and 70% response criteria, a post-hoc analysis showed.
